Cost agency unconvinced by Botox for migraine

LONDON (Reuters) - Healthcare cost-effectiveness body NICE is not convinced that Allergan's anti-wrinkle injection Botox is worth using to treat migraines.

Related Stories

• EU blames Iceland for collapse of "mackerel war" talks
• Murdoch arrives in London to quell staff backlash
• EU agency says weight-loss drugs risk acceptable
• Retailers closed 14 stores a day in 2011 - report
• Snow can't stop John Lewis sales rise

Source: http://uk.reuters.com/article/2012/02/16/uk-uk-cost-agency-migraine-idUKTRE81F28O20120216?feedType=RSS&feedName=domesticNews

beauty computers technology pets